Following a $194-million settlement tied to a significant EV contract, ATS Company (ATS Company Inventory Quote, Chart, Information, Analysts, Financials TSX:ATS) is poised to enhance key worth metrics, making now an excellent time to revisit the inventory reiterating his “Purchase” ranking and C$52.00 goal.
ATS supplies superior automation options for international producers throughout varied industries, together with life sciences, meals and beverage, transportation, shopper merchandise, and vitality. ATS employs over 7,500 folks throughout greater than 65 manufacturing websites and 85 workplaces worldwide, together with North America, Europe, Asia, and Oceania.
Stifel analyst Justin Keywood stated in a June 4 word that the agency was happy to host ATS Company’s CEO and CFO at its Boston Cross Sector Perception Convention.
He stated ATS is concentrating on a 400-basis-point margin enlargement over 4 years, aiming to achieve a 15% Adjusted EBIT margin, or about 17.5% Adjusted EBITDA. Whereas the aim has been in place for a while, it now has a clearer timeline following the EV sector unwind and powerful backlog and bookings, Keywood stated.
The corporate’s most up-to-date Adjusted EBITDA margin was 13.5%.
“Scale and working leverage shall be a driving issue, together with potential M&A,” Keywood stated. “Standardization and labour productiveness to additionally contribute, together with a mix-shift change profit with Life Sciences to comprise +60% of gross sales (increased margin phase), vs. ~40%, 18-months in the past and EV, 8-10% (decrease margins). We see credibility within the margin enlargement aim, given ATS achieved 16.3% adj. EBITDA in FQ3/2024, previous to the EV unwind and hit a earlier 500bps, 5-year enlargement aim however was not sustained.”
ATS’ CEO described the M&A pipeline as “very lively,” noting the corporate has accomplished round 20 offers and deployed $2-billion underneath the present administration crew.
“The observe file of M&A has been beneficial, together with rising ROIC to a peak of close to 14%, previous to the EV unwind,” Keywood stated. “ATS is concentrated on buying inside Life Sciences, Meals & Beverage and providers property that develop a number of verticals. There may be sure Nuclear property within the funnel however longer cultivation durations. We view M&A as constructive catalysts for the inventory that would recommend margin enlargement with scale advantages, depending on the asset.”
Keywood expects ATS to generate C$369-million in Adjusted EBITDA on income of C$2.68 billion in fiscal 2025. He forecasts these figures to enhance to C$433-million in EBITDA on C$2.94 billion in income in fiscal 2026.
ATS ended fiscal This fall with internet debt at 3.9x EBITDA, above its most popular 2–3x vary, primarily attributable to a $360-million accounts receivable dispute with a significant auto/EV shopper. A $194-million settlement, to be paid by the tip of June, is anticipated to scale back leverage by 0.25x, with a further 0.4x discount forecast over the subsequent 12 months. Administration indicated leverage may fall beneath 3.0x by the tip of fiscal 2026. The auto/EV contract had unfavourable phrases, together with no deposits or milestone billing, however future money circulation is anticipated to enhance. Whereas M&A might briefly carry leverage once more, ATS maintains strict acquisition standards. The inventory trades at 12x ahead EBITDA, down from 15x throughout stronger market circumstances 18 months in the past, earlier than the EV-related slowdown.
“We see valuation increasing with a mix of natural development, margin enlargement and deleveraging with M&A serving as potential catalysts,” Keywood stated. “Our C$52 goal worth is predicated on 14x F2026E EBITDA. We see a time to revisit ATS.”
-30-
